Literature DB >> 2350921

Influence of tumor transplantation methods on tumor growth rate and metastatic potential of solitary tumors derived from metastases.

J P Volpe1, L Milas.   

Abstract

This study was performed to determine whether the growth rate and metastatic potential of tumors generated by spontaneous lung metastases is influenced by transplantation methods. Three different tumors syngeneic to C3Hf/Kam mice were studied: the SA-NH and SA-4020 sarcomas and the hepatocarcinoma HCA-I. Solitary tumors in the legs of mice were generated by a single metastatic nodule taken at random from lung metastases, by a single metastatic nodule taken from each mouse with the highest number of metastases, by a mixture of cells from lung metastases taken randomly, or by a mixture of cells from primary leg tumors. These transplantation procedures were repeated for two to four isotransplant generations. Repeated isotransplants of primary tumors showed little if any change in the growth rate and metastatic spread. In contrast, primary tumors derived from spontaneous metastases frequently exhibited a decrease in their growth rate and an increase in metastatic potential. This was particularly frequent when tumors were established from single metastatic nodules taken randomly from the lung, or taken from lungs that contained the largest number of metastatic nodules. The magnitude of this change varied greatly among the three tumors studied. Increased metastatic formation in the lung was also frequently associated with slower growth of the primary tumors. Thus, transplantation methods used for establishing primary tumors have an important influence on the metastatic potential of tumor transplants.

Entities:  

Mesh:

Year:  1990        PMID: 2350921     DOI: 10.1007/bf01810682

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  20 in total

1.  Effect of radiation-induced injury of tumor bed stroma on metastatic spread of murine sarcomas and carcinomas.

Authors:  L Milas; H Hirata; N Hunter; L J Peters
Journal:  Cancer Res       Date:  1988-04-15       Impact factor: 12.701

2.  Characterization of tumor lines derived from spontaneous metastases of a transplanted murine sarcoma.

Authors:  A Mantovani; R Giavazzi; G Alessandri; F Spreafico; S Garattini
Journal:  Eur J Cancer       Date:  1981-01       Impact factor: 9.162

3.  Polyomavirus-transformed FR 3T3 rat cells are able to form metastases in syngeneic rats.

Authors:  O De Lapeyriere; D Arnaud; M Courcoul; J Planche; G Meyer; F Birg
Journal:  Virology       Date:  1986-01-15       Impact factor: 3.616

4.  Cancer metastasis is selective or random depending on the parent tumour population.

Authors:  J E Talmadge; I J Fidler
Journal:  Nature       Date:  1982-06-17       Impact factor: 49.962

5.  Chromosomal changes associated with progression of the Dunning R-3327 rat prostatic adenocarcinoma system.

Authors:  N Wake; J Isaacs; A A Sandberg
Journal:  Cancer Res       Date:  1982-10       Impact factor: 12.701

6.  Clones with different metastatic capacity and variant selection during metastasis: a problematic relationship.

Authors:  P Nanni; C De Giovanni; P L Lollini; G Nicoletti; G Prodi
Journal:  J Natl Cancer Inst       Date:  1986-01       Impact factor: 13.506

7.  Isolation and characterization of metastatic sublines from a murine transitional cell bladder carcinoma.

Authors:  B A Barut; J E Klaunig
Journal:  Clin Exp Metastasis       Date:  1986 Jan-Mar       Impact factor: 5.150

8.  Heterogeneity in a spontaneous mouse lung carcinoma: selection and characterisation of stable metastatic variants.

Authors:  M G Layton; L M Franks
Journal:  Br J Cancer       Date:  1984-04       Impact factor: 7.640

9.  Do metastases arise from pre-existing subpopulations of cancer cells?

Authors:  L Weiss; J C Holmes; P M Ward
Journal:  Br J Cancer       Date:  1983-01       Impact factor: 7.640

10.  Effect of cyclosporin A on the growth and spontaneous metastasis of syngeneic animal tumours.

Authors:  S A Eccles; S E Heckford; P Alexander
Journal:  Br J Cancer       Date:  1980-08       Impact factor: 7.640

View more
  12 in total

Review 1.  Technical considerations for studying cancer metastasis in vivo.

Authors:  D R Welch
Journal:  Clin Exp Metastasis       Date:  1997-05       Impact factor: 5.150

2.  Metastasizing lung carcinomas in Hann: Wistar rats.

Authors:  K Kamino; M Kohler; U Mohr
Journal:  Clin Exp Metastasis       Date:  1992-07       Impact factor: 5.150

3.  A unique allogenic model of metastatic pheochromocytoma: PC12 rat pheochromocytoma xenografts to nude mice and establishment of metastases-derived PC12 variants.

Authors:  A Zielke; R S Bresalier; A E Siperstein; O H Clark; M Rothmund; Q Y Duh
Journal:  Clin Exp Metastasis       Date:  1998-05       Impact factor: 5.150

4.  In vivo investigation of hybrid Paclitaxel nanocrystals with dual fluorescent probes for cancer theranostics.

Authors:  Christin P Hollis; Heidi L Weiss; B Mark Evers; Richard A Gemeinhart; Tonglei Li
Journal:  Pharm Res       Date:  2013-04-26       Impact factor: 4.200

5.  Morphological heterogeneity and phenotypical instability versus metastatic stability in the murine tumor model ER 15-P.

Authors:  G Edel; A Roessner; B Deneke; B Wörmann
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

6.  The invasive and metastatic properties of hormone-independent but hormone-responsive variants of MCF-7 human breast cancer cells.

Authors:  E W Thompson; N Brünner; J Torri; M D Johnson; V Boulay; A Wright; M E Lippman; P S Steeg; R Clarke
Journal:  Clin Exp Metastasis       Date:  1993-01       Impact factor: 5.150

7.  Drug sensitivity and metastatic ability in B16 melanoma cells.

Authors:  A Jang; R P Hill
Journal:  Clin Exp Metastasis       Date:  1991 Jul-Aug       Impact factor: 5.150

Review 8.  Hormonal carcinogenesis in breast cancer: cellular and molecular studies of malignant progression.

Authors:  R Clarke; T Skaar; K Baumann; F Leonessa; M James; J Lippman; E W Thompson; C Freter; N Brunner
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

Review 9.  Human breast cancer cell line xenografts as models of breast cancer. The immunobiologies of recipient mice and the characteristics of several tumorigenic cell lines.

Authors:  R Clarke
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

Review 10.  Biomedical application of low molecular weight heparin/protamine nano/micro particles as cell- and growth factor-carriers and coating matrix.

Authors:  Masayuki Ishihara; Satoko Kishimoto; Makoto Takikawa; Hidemi Hattori; Shingo Nakamura; Masafumi Shimizu
Journal:  Int J Mol Sci       Date:  2015-05-22       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.